Coastlands Capital LP - 05 Nov 2025 SCHEDULE 13G Report for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP)

Filing Manager
Coastlands Capital LP
Reporting Manager
Coastlands Capital LP
Security
Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share
Symbol
NEUP
Shares outstanding
2,352,941 shares
Disclosed Ownership
120,000 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
05 Nov 2025, 10:31:31 UTC
Date of event
05 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Coastlands Capital LP disclosed 5.1% ownership in Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP) on 05 Nov 2025."

Quick Takeaways

  • Coastlands Capital LP filed SCHEDULE 13G for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP).
  • Disclosed ownership: 5.1%.
  • Date of event: 05 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 05 Nov 2025, 10:31.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Coastlands Capital LP 5.1% 120,000 0 120,000 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital LLC
Coastlands Capital Partners LP 5.1% 120,000 0 120,000 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Coastlands Capital GP LLC 5.1% 120,000 0 120,000 /s/ Mark Shamia Chief Operating Officer
Coastlands Capital LLC 5.1% 120,000 0 120,000 /s/ Mark Shamia Chief Operating Officer
Matthew D. Perry 5.1% 120,000 0 120,000 /s/ Matthew D. Perry Reporting person

Sponsored